MINNEAPOLIS — U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a ...

The Layer 7 Cortical Interface is a high-resolution cortical electrode array for use in recording, monitoring, and ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

Shares of Adagio Medical Holdings, Inc. (ADGM) experienced a significant surge in retail investor interest last week as they ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

The cuts to the FDA are just one piece of the budget proposal, which looks to slash the HHS’ discretionary spending by ...

The Trump administration’s recent announcement that it plans to eliminate about 3,500 FDA jobs is creating uncertainty among ...

Precision Neuroscience, a prominent rival of Elon Musk-owned Neuralink, has announced that its brain-computer interface (BCI) ...

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

Get Instant Summarized Text (Gist) The FDA's approval of high-risk medical devices has reached a 10-year low, attributed to significant workforce reductions. Despite an increase in pending ...